 |
US:
(339)-368-6001 |
| Intl.:
+1-339-368-6001 |
|
|
| |
|
|
|
|
|
|
US demand to increase 7.2% annually through 2012
Demand for cosmeceutical products is expected to increase 7.2 percent per year to $9.4 billion in 2012, propelled by a stream of new and technologically advanced product introductions offering age-defying and other appearanceenhancing benefits for an aging population. The rapid growth of the cosmeceutical market will continue to be based on a combination of science and astute marketing, with evidence regarding product claims far from conclusive in many instances.
Limiting opportunities will be competition from alternative treatments, such as laser resurfacing and cosmetic surgery, which often offer more dramatic results, though at a greater cost in terms of time, money and safety. Cosmeceutical products also face intense pricing competition due to the growing market penetration of private label cosmeceutical brands and the rapid commoditization of innovative ingredients and products.
Skin care products to remain dominant segment
Skin care products will account for over 60 percent of all cosmeceutical product demand in 2012. Anti-aging products will achieve above-average growth, with gains driven by a highly receptive, fastexpanding group of middle-aged and relatively affluent consumers who want to prevent or redress visible damage to the skin caused by aging, ultraviolet radiation and other environmental stressors. Improved formulations will further promote the use of age-defying products.
More Details
Injectable products to see fastest growth
Injectable products are expected to experience the fastest growth among cosmeceutical products, achieving double-digit annual gains through 2012. Strong prospects for these products are the result of growing demand and acceptance on the consumer side and the increasing availability and proficiency of practitioners. The aging of the US population, an increasingly competitive work force and continued exposure to beauty “ideals” in entertainment and advertising are expected to spur continued interest in professional products.
Botulinum toxin, hyaluronic acid among best prospects
Demand for cosmeceutical chemicals will grow as producers increasingly develop more effective, value-added active ingredients to add to their product formulations. Chemicals used in injectable products will drive gains, with strong advances expected for botulinum toxin, the key ingredient in BOTOX; and hyaluronic acid, the substance on which recently introduced dermal fillers RESTYLANE, JUVEDERM and ELEVESS are based. Hyaluronic acid is finding greater use in over-the-counter age-defying products, particularly skin care items.
Other chemicals expected to record rapid gains include amino acids and antioxidants (e.g., vitamins A and C), which are the active ingredients in many anti-aging creams and lotions; botanical extracts, which serve a variety of cosmeceutical functions; and beta hydroxy acids, which have become an important ingredient in various skin care products due to their ability to offer exfoliant and cell renewal properties with less risk of adverse reactions than other chemicals.
Study coverage
This new industry study, Cosmeceuticals, presents historical demand data (1997, 2002, 2007) and forecasts for 2012 and 2017 by product and chemical. The study also considers market environment factors, evaluates company market share and profiles leading competitors.
|
|
- INTRODUCTION
- I. EXECUTIVE SUMMARY
- II. MARKET ENVIRONMENT
- General
- Macroeconomic Overview
- Demographic Trends
- Consumer Spending
- Physicians
- Spa Industry Outlook
- Dermatological Conditions
- Hair Loss
- Skin Conditions
- Cosmetic & Toiletry Market
- Skin Care Products
- Hair Care Products
- Oral Hygiene Products
- Other Cosmetics & Toiletries
- Cosmetic Surgery Procedures
- Dermatological Pharmaceutical Overview
- Nanotechnology in Cosmeceuticals
- Regulatory Considerations
- Historical Market Trends
- International Activity & Foreign Trade
- III. COSMECEUTICAL PRODUCTS
- General
- Skin Care Cosmeceuticals
- Age-Defying Products
- Types
- Applications
- Acne Preparations
- Professional Acne Preparations
- Over-The-Counter Acne Preparations
- Medicated Lotions
- Sun Care Products
- Other Skin Care Products
- Hair Care Cosmeceuticals
- Hair Growth Products
- Finasteride-Based
- Minoxidil-Based & Other
- Anti-Dandruff Shampoos
- Injectable Cosmeceuticals
- Botulinum Toxin-Based
- Tissue Fillers
- Hyaluronic Acid
- Other Tissue Fillers
- Collagen
- Calcium Hydroxylapatite
- Synthetic Polymers
- Other Injectables
- Lip Care Products
- Tooth Whiteners
- Professional Tooth Whiteners
- Over-The-Counter Tooth Whiteners
- Other Cosmeceutical Products
- Ingestibles
- Color Cosmetics
- Anti-Cellulite/Body Slimming
- Breast/Penis Enhancers
- Hair Growth Retardants
- Nail, Hand & Foot
- All Other Cosmeceutical Products
- IV. COSMECEUTICAL CHEMICALS
- General
- Antioxidants
- Vitamin A Compounds
- Vitamin E Compounds
- Vitamin C Compounds
- Coenzyme Q10 & Other
- Sunscreens
- Organic
- Inorganic
- Acids
- Alpha Hydroxy Acids
- Other Acids
- Enzymes
- Botulinum Toxin
- Other Enzymes
- Proteins
- Collagen
- Amino Acids
- Elastin
- Other Proteins
- Botanicals
- Other
- Finasteride
- Minoxidil
- All Other
- V. INDUSTRY STRUCTURE
- General
- Market Share
- Cosmeceutical Products
- Cosmeceutical Chemicals
- Marketing & Distribution
- Manufacturing
- Competitive Strategies
- Research & Development
- Cooperative Agreements
- Acquisitions & Divestitures
- Company Profiles
- Active Organics Incorporated
- Allergan Incorporated
- Arch Chemicals Incorporated
- Ashland Incorporated
- Avon Products Incorporated
- BASF SE
- Bayer AG
- Beiersdorf AG
- Ciba Specialty Chemicals Holding Incorporated
- Clariant International Limited
- Clinique Laboratories LLC, see Estee Lauder Companies Incorporated
- Cognis Deutschland GmbH & Company KG
- Colgate-Palmolive Company
- Croda International plc
- Desert Whale Jojoba Company Incorporated
- DuPont (EI) de Nemours
- Eastman Chemical Company
- Estee Lauder Companies Incorporated
- Evonik Industries AG
- Galderma SA , see L’Oreal SA
- Groupe Corneal Laboratoires SA, see Allergan
- Indena SpA
- International Specialty Products Incorporated
- Janson Beckett Incorporated
- Johnson & Johnson
- Kao Corporation
- Kyowa Hakko Kogyo Company Limited
- Laboratoires La Prairie AG, see Beiersdorf AG
- Laboratoires Serobiologiques, see Cognis Deutschland GmbH & Company KG
- L’Oreal SA
- McNeil Consumer Healthcare, see Johnson & Johnson
- Medicis Pharmaceutical Corporation
- Merck & Company Incorporated
- Murad Incorporated
- Neutrogena Corporation, see Johnson & Johnson
- NIOXIN Research Laboratories Incorporated, see Procter & Gamble Company
- Novartis AG
- Obagi Medical Products Incorporated
- Ojon Corporation, see Estee Lauder Companies
- OrthoNeutrogena, see Johnson & Johnson
- Oxonica plc, see BASF SE
- PerriconeMD Cosmeceuticals
- Pfizer Incorporated
- Procter & Gamble Company
- Rhodia SA
- RoC, see Johnson & Johnson
- Roche Holding Limited
- Royal DSM NV
- Schering-Plough Corporation
- Sederma SA, see Croda International plc
- SkinMedica Incorporated
- Symrise AG
- The Body Shop International plc, see L’Oreal SA
- Therapeutic Peptides Incorporated, see Symrise AG
- Unilever Group
- Vincience, see International Specialty Products
- Yves Saint Laurent Beaute, see L’Oreal SA
- Other Companies Mentioned in Study
- LIST OF TABLES
- SECTION I -- EXECUTIVE SUMMARY
- Summary Table
- SECTION II -- MARKET ENVIRONMENT
- 1 Macroeconomic Indicators
- 2 Population & Households
- 3 Personal Consumption Expenditures
- 4 Physicians
- 5 Spa Facilities by Type
- 6 Selected Aesthetic-Related Conditions
- 7 Cosmetic & Toiletry Supply & Demand
- 8 Skin Care Product Supply & Demand
- 9 Hair Care Product Supply & Demand
- 10 Oral Hygiene Product Supply & Demand
- 11 Other Cosmetic & Toiletry Product Supply & Demand
- 12 Cosmetic Surgery Procedures
- 13 Dermatological Pharmaceutical Supply & Demand
- 14 Cosmeceutical Chemical Market, 1997-2007
- SECTION III -- COSMECEUTICAL PRODUCTS
- 1 Cosmeceutical Product Demand
- 2 Skin Care Cosmeceutical Product Demand
- 3 Age-Defying Cosmeceutical Product Demand
- 4 Acne Preparation Cosmeceutical Product Demand
- 5 Medicated Lotion Cosmeceutical Product Demand
- 6 Sun Protection Cosmeceutical Product Demand
- 7 Other Skin Care Cosmeceutical Product Demand
- 8 Hair Care Cosmeceutical Product Demand
- 9 Hair Growth Cosmeceutical Product Demand
- 10 Anti-Dandruff Cosmeceutical Product Demand
- 11 Injectable Cosmeceutical Product Demand
- 12 Botulinum Toxin Cosmeceutical Product Demand
- 13 Tissue Filler Cosmeceutical Product Demand
- 14 Other Injectable Cosmeceutical Product Demand
- 15 Lip Care Product Demand
- 16 Tooth Whitener Demand
- 17 Other Cosmeceutical Product Demand
- SECTION IV -- COSMECEUTICAL CHEMICALS
- 1 Cosmeceutical Chemical Demand
- 2 Antioxidants: Cosmeceutical Applications
- 3 Sunscreens: Cosmeceutical Applications
- 4 Acids: Cosmeceutical Applications
- 5 Enzymes: Cosmeceutical Applications
- 6 Proteins: Cosmeceutical Applications
- 7 Botanicals: Cosmeceutical Applications
- 8 Other Cosmeceutical Chemical Demand
- SECTION V -- INDUSTRY STRUCTURE
- 1 US Cosmeceutical Product & Chemical Sales by Company, 2007
- 2 R&D Spending Patterns: Selected Cosmeceutical Suppliers
- 3 Selected Cooperative Agreements
- 4 Selected Acquisitions & Divestitures
- LIST OF CHARTS
- SECTION III -- COSMECEUTICAL PRODUCTS
- 1 Cosmeceutical Product Demand by Type, 2007
- 2 Skin Care Cosmeceutical Product Demand by Type, 2007
- SECTION IV -- COSMECEUTICAL CHEMICALS
- 1 Cosmeceutical Chemical Demand by Type, 2007
- SECTION V -- INDUSTRY STRUCTURE
- 1 US Cosmeceutical Product Market Share by Company, 2007
- 2 US Cosmeceutical Chemical Market Share by Company, 2007
|
|
|
